|
Hepatitis D Global Clinical Trials Review, H2, 2016 |
Aug 24 2016 |
56 |
Global |
$2,500.00 |
|
|
Hepatitis C Global Clinical Trials Review, H2, 2016 |
Aug 24 2016 |
1747 |
Global |
$2,500.00 |
|
|
Hepatitis E Global Clinical Trials Review, H2, 2016 |
Aug 24 2016 |
31 |
Global |
$2,500.00 |
|
|
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016 |
Aug 24 2016 |
903 |
Global |
$2,500.00 |
|
|
Dermatophytosis Global Clinical Trials Review, H2, 2016 |
Aug 24 2016 |
88 |
Global |
$2,500.00 |
|
|
Anthrax Global Clinical Trials Review, H2, 2016 |
Aug 24 2016 |
64 |
Global |
$2,500.00 |
|
|
Hepatitis B Global Clinical Trials Review, H2, 2016 |
Aug 24 2016 |
785 |
Global |
$2,500.00 |
|
|
Botulism Global Clinical Trials Review, H2, 2016 |
Aug 24 2016 |
33 |
Global |
$2,500.00 |
|
|
Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016 |
Aug 24 2016 |
46 |
Global |
$2,500.00 |
|
|
Amnesia Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
49 |
Global |
$2,500.00 |
|
|
Cerebral Palsy Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
110 |
Global |
$2,500.00 |
|
|
Ataxia-Telangiectasia (Louis-Bar Syndrome) Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
46 |
Global |
$2,500.00 |
|
|
Cervical Dystonia Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
73 |
Global |
$2,500.00 |
|
|
Chronic Spinal Cord Injury Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
40 |
Global |
$2,500.00 |
|
|
Bulimia Nervosa Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
41 |
Global |
$2,500.00 |
|
|
Carpal Tunnel Syndrome Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
65 |
Global |
$2,500.00 |
|
|
Autism Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
226 |
Global |
$2,500.00 |
|
|
Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
57 |
Global |
$2,500.00 |
|
|
Ataxia Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
52 |
Global |
$2,500.00 |
|
|
Agoraphobia Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
49 |
Global |
$2,500.00 |
|
|
Cerebellar Ataxia Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
38 |
Global |
$2,500.00 |
|
|
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
182 |
Global |
$2,500.00 |
|
|
Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
74 |
Global |
$2,500.00 |
|
|
Cerebral Vasospasm Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
57 |
Global |
$2,500.00 |
|
|
Abdominal Pain Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
108 |
Global |
$2,500.00 |
|
|
Alzheimer's Disease Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
912 |
Global |
$2,500.00 |
|
|
Batten Disease Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
35 |
Global |
$2,500.00 |
|
|
Asperger Syndrome Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
50 |
Global |
$2,500.00 |
|
|
Acute Back Pain Global Clinical Trials Review, H2, 2016 |
Aug 17 2016 |
39 |
Global |
$2,500.00 |
|
|
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines |
Aug 16 2016 |
199 |
Philippines |
$1,995.00 |
|
